Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Hamostaseologie|October 18, 2018
Anticoagulation in Atherosclerotic DiseaseSamer Al Said, Christoph Bode, Daniel Duerschmied
Hamostaseologie|October 18, 2021
Non-Vitamin K Antagonist Oral Anticoagulants in Coronary Artery DiseaseSamer Al Said, Michael Ellscheid, Eleftherios T Beltsios, et al.
The Cochrane Database of Systematic Reviews|December 21, 2019
Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysisSamer Al Said, Samer Alabed, Klaus Kaier, et al.
The Cochrane Database of Systematic Reviews|February 24, 2025
Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysisSamer Al Said, Klaus Kaier, Edris Nury, et al.
The Cochrane Database of Systematic Reviews|January 24, 2024
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysisSamer Al Said, Klaus Kaier, Wael Sumaya, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 11, 2015
Dimethyloxalylglycine treatment of brain-dead donor rats improves both donor and graft left ventricular function after heart transplantationPéter Hegedűs, Shiliang Li, Sevil Korkmaz-Icöz, et al.
Journal of the American College of Cardiology|February 5, 2025
Long-Term Lipid Lowering With Evolocumab in Older IndividualsSamer Al Said, Michelle L O'Donoghue, Xinhui Ran, et al.
Circulation|January 30, 2026
Systemic Embolic Events in Atrial Fibrillation: An Individual Patient Data Meta-analysis of 71 683 Participants Randomized to NOAC Versus WarfarinSamer Al Said, Eugene Braunwald, Michael G Palazzolo, et al.
Cardiovascular Diabetology|May 8, 2016
Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathwaySevil Korkmaz-Icöz, Samer Al Said, Tamás Radovits, et al.
Circulation|June 23, 2025
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 TrialSamer Al Said, Siddharth M Patel, Robert P Giugliano, et al.
Pageof 2